Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1061287

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1061287

Global STD Diagnostics Market Insights and Forecast to 2028

PUBLISHED:
PAGES: 125 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

STD Diagnostics is the procedure to test if the patient have the STD.

Market Analysis and Insights: Global STD Diagnostics Market

The global STD Diagnostics market size is projected to reach US$ 296290 million by 2028, from US$ 184080 million in 2021, at a CAGR of 6.9% during 2022-2028.

Fully considering the economic change by this health crisis, Chlamydia Testing accounting for % of the STD Diagnostics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Laboratory Testing segment is altered to an % CAGR throughout this forecast period.

China STD Diagnostics market size is valued at US$ million in 2021, while the North America and Europe STD Diagnostics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe STD Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global STD Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global STD Diagnostics market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global STD Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global STD Diagnostics market.

Global STD Diagnostics Scope and Market Size

STD Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global STD Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Chlamydia Testing
  • Syphilis Testing
  • Gonorrhea Testing
  • Herpes Simplex Virus Testing
  • Human Papilloma Virus Testing
  • Human Immunodeficiency Virus Testing
  • Chancroid Testing

Segment by Application

  • Laboratory Testing
  • Point of Care Testing

By Company

  • Abbott
  • ADI/American Diagnostica
  • Agilent Technologies
  • Alere/Biosite/Inverness
  • Axis-Shield
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio/Data
  • Decode Genetics
  • Diadexus
  • Diagnocure
  • Diagnostica Stago/Trinity Biotech
  • Diamedix
  • Polymedco
  • Qiagen
  • Roche
  • SDIX
  • Sequenom
  • Siemens
  • Sienco
  • Sysmex
  • Takara Bio
  • ThermoFisher
  • Tosoh
  • Wako
  • Zycare/Alere

By Region

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global STD Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Chlamydia Testing
    • 1.2.3 Syphilis Testing
    • 1.2.4 Gonorrhea Testing
    • 1.2.5 Herpes Simplex Virus Testing
    • 1.2.6 Human Papilloma Virus Testing
    • 1.2.7 Human Immunodeficiency Virus Testing
    • 1.2.8 Chancroid Testing
  • 1.3 Market by Application
    • 1.3.1 Global STD Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Laboratory Testing
    • 1.3.3 Point of Care Testing
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global STD Diagnostics Market Perspective (2017-2028)
  • 2.2 STD Diagnostics Growth Trends by Region
    • 2.2.1 STD Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 STD Diagnostics Historic Market Size by Region (2017-2022)
    • 2.2.3 STD Diagnostics Forecasted Market Size by Region (2023-2028)
  • 2.3 STD Diagnostics Market Dynamics
    • 2.3.1 STD Diagnostics Industry Trends
    • 2.3.2 STD Diagnostics Market Drivers
    • 2.3.3 STD Diagnostics Market Challenges
    • 2.3.4 STD Diagnostics Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top STD Diagnostics Players by Revenue
    • 3.1.1 Global Top STD Diagnostics Players by Revenue (2017-2022)
    • 3.1.2 Global STD Diagnostics Revenue Market Share by Players (2017-2022)
  • 3.2 Global STD Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by STD Diagnostics Revenue
  • 3.4 Global STD Diagnostics Market Concentration Ratio
    • 3.4.1 Global STD Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by STD Diagnostics Revenue in 2021
  • 3.5 STD Diagnostics Key Players Head office and Area Served
  • 3.6 Key Players STD Diagnostics Product Solution and Service
  • 3.7 Date of Enter into STD Diagnostics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 STD Diagnostics Breakdown Data by Type

  • 4.1 Global STD Diagnostics Historic Market Size by Type (2017-2022)
  • 4.2 Global STD Diagnostics Forecasted Market Size by Type (2023-2028)

5 STD Diagnostics Breakdown Data by Application

  • 5.1 Global STD Diagnostics Historic Market Size by Application (2017-2022)
  • 5.2 Global STD Diagnostics Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America STD Diagnostics Market Size (2017-2028)
  • 6.2 North America STD Diagnostics Market Size by Type
    • 6.2.1 North America STD Diagnostics Market Size by Type (2017-2022)
    • 6.2.2 North America STD Diagnostics Market Size by Type (2023-2028)
    • 6.2.3 North America STD Diagnostics Market Share by Type (2017-2028)
  • 6.3 North America STD Diagnostics Market Size by Application
    • 6.3.1 North America STD Diagnostics Market Size by Application (2017-2022)
    • 6.3.2 North America STD Diagnostics Market Size by Application (2023-2028)
    • 6.3.3 North America STD Diagnostics Market Share by Application (2017-2028)
  • 6.4 North America STD Diagnostics Market Size by Country
    • 6.4.1 North America STD Diagnostics Market Size by Country (2017-2022)
    • 6.4.2 North America STD Diagnostics Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe STD Diagnostics Market Size (2017-2028)
  • 7.2 Europe STD Diagnostics Market Size by Type
    • 7.2.1 Europe STD Diagnostics Market Size by Type (2017-2022)
    • 7.2.2 Europe STD Diagnostics Market Size by Type (2023-2028)
    • 7.2.3 Europe STD Diagnostics Market Share by Type (2017-2028)
  • 7.3 Europe STD Diagnostics Market Size by Application
    • 7.3.1 Europe STD Diagnostics Market Size by Application (2017-2022)
    • 7.3.2 Europe STD Diagnostics Market Size by Application (2023-2028)
    • 7.3.3 Europe STD Diagnostics Market Share by Application (2017-2028)
  • 7.4 Europe STD Diagnostics Market Size by Country
    • 7.4.1 Europe STD Diagnostics Market Size by Country (2017-2022)
    • 7.4.2 Europe STD Diagnostics Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific STD Diagnostics Market Size (2017-2028)
  • 8.2 Asia-Pacific STD Diagnostics Market Size by Type
    • 8.2.1 Asia-Pacific STD Diagnostics Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific STD Diagnostics Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific STD Diagnostics Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific STD Diagnostics Market Size by Application
    • 8.3.1 Asia-Pacific STD Diagnostics Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific STD Diagnostics Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific STD Diagnostics Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific STD Diagnostics Market Size by Region
    • 8.4.1 Asia-Pacific STD Diagnostics Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific STD Diagnostics Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America STD Diagnostics Market Size (2017-2028)
  • 9.2 Latin America STD Diagnostics Market Size by Type
    • 9.2.1 Latin America STD Diagnostics Market Size by Type (2017-2022)
    • 9.2.2 Latin America STD Diagnostics Market Size by Type (2023-2028)
    • 9.2.3 Latin America STD Diagnostics Market Share by Type (2017-2028)
  • 9.3 Latin America STD Diagnostics Market Size by Application
    • 9.3.1 Latin America STD Diagnostics Market Size by Application (2017-2022)
    • 9.3.2 Latin America STD Diagnostics Market Size by Application (2023-2028)
    • 9.3.3 Latin America STD Diagnostics Market Share by Application (2017-2028)
  • 9.4 Latin America STD Diagnostics Market Size by Country
    • 9.4.1 Latin America STD Diagnostics Market Size by Country (2017-2022)
    • 9.4.2 Latin America STD Diagnostics Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa STD Diagnostics Market Size (2017-2028)
  • 10.2 Middle East & Africa STD Diagnostics Market Size by Type
    • 10.2.1 Middle East & Africa STD Diagnostics Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa STD Diagnostics Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa STD Diagnostics Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa STD Diagnostics Market Size by Application
    • 10.3.1 Middle East & Africa STD Diagnostics Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa STD Diagnostics Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa STD Diagnostics Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa STD Diagnostics Market Size by Country
    • 10.4.1 Middle East & Africa STD Diagnostics Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa STD Diagnostics Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Abbott
    • 11.1.1 Abbott Company Details
    • 11.1.2 Abbott Business Overview
    • 11.1.3 Abbott STD Diagnostics Introduction
    • 11.1.4 Abbott Revenue in STD Diagnostics Business (2017-2022)
    • 11.1.5 Abbott Recent Developments
  • 11.2 ADI/American Diagnostica
    • 11.2.1 ADI/American Diagnostica Company Details
    • 11.2.2 ADI/American Diagnostica Business Overview
    • 11.2.3 ADI/American Diagnostica STD Diagnostics Introduction
    • 11.2.4 ADI/American Diagnostica Revenue in STD Diagnostics Business (2017-2022)
    • 11.2.5 ADI/American Diagnostica Recent Developments
  • 11.3 Agilent Technologies
    • 11.3.1 Agilent Technologies Company Details
    • 11.3.2 Agilent Technologies Business Overview
    • 11.3.3 Agilent Technologies STD Diagnostics Introduction
    • 11.3.4 Agilent Technologies Revenue in STD Diagnostics Business (2017-2022)
    • 11.3.5 Agilent Technologies Recent Developments
  • 11.4 Alere/Biosite/Inverness
    • 11.4.1 Alere/Biosite/Inverness Company Details
    • 11.4.2 Alere/Biosite/Inverness Business Overview
    • 11.4.3 Alere/Biosite/Inverness STD Diagnostics Introduction
    • 11.4.4 Alere/Biosite/Inverness Revenue in STD Diagnostics Business (2017-2022)
    • 11.4.5 Alere/Biosite/Inverness Recent Developments
  • 11.5 Axis-Shield
    • 11.5.1 Axis-Shield Company Details
    • 11.5.2 Axis-Shield Business Overview
    • 11.5.3 Axis-Shield STD Diagnostics Introduction
    • 11.5.4 Axis-Shield Revenue in STD Diagnostics Business (2017-2022)
    • 11.5.5 Axis-Shield Recent Developments
  • 11.6 Beckman Coulter/Danaher
    • 11.6.1 Beckman Coulter/Danaher Company Details
    • 11.6.2 Beckman Coulter/Danaher Business Overview
    • 11.6.3 Beckman Coulter/Danaher STD Diagnostics Introduction
    • 11.6.4 Beckman Coulter/Danaher Revenue in STD Diagnostics Business (2017-2022)
    • 11.6.5 Beckman Coulter/Danaher Recent Developments
  • 11.7 Becton Dickinson
    • 11.7.1 Becton Dickinson Company Details
    • 11.7.2 Becton Dickinson Business Overview
    • 11.7.3 Becton Dickinson STD Diagnostics Introduction
    • 11.7.4 Becton Dickinson Revenue in STD Diagnostics Business (2017-2022)
    • 11.7.5 Becton Dickinson Recent Developments
  • 11.8 Bio/Data
    • 11.8.1 Bio/Data Company Details
    • 11.8.2 Bio/Data Business Overview
    • 11.8.3 Bio/Data STD Diagnostics Introduction
    • 11.8.4 Bio/Data Revenue in STD Diagnostics Business (2017-2022)
    • 11.8.5 Bio/Data Recent Developments
  • 11.9 Decode Genetics
    • 11.9.1 Decode Genetics Company Details
    • 11.9.2 Decode Genetics Business Overview
    • 11.9.3 Decode Genetics STD Diagnostics Introduction
    • 11.9.4 Decode Genetics Revenue in STD Diagnostics Business (2017-2022)
    • 11.9.5 Decode Genetics Recent Developments
  • 11.10 Diadexus
    • 11.10.1 Diadexus Company Details
    • 11.10.2 Diadexus Business Overview
    • 11.10.3 Diadexus STD Diagnostics Introduction
    • 11.10.4 Diadexus Revenue in STD Diagnostics Business (2017-2022)
    • 11.10.5 Diadexus Recent Developments
  • 11.11 Diagnocure
    • 11.11.1 Diagnocure Company Details
    • 11.11.2 Diagnocure Business Overview
    • 11.11.3 Diagnocure STD Diagnostics Introduction
    • 11.11.4 Diagnocure Revenue in STD Diagnostics Business (2017-2022)
    • 11.11.5 Diagnocure Recent Developments
  • 11.12 Diagnostica Stago/Trinity Biotech
    • 11.12.1 Diagnostica Stago/Trinity Biotech Company Details
    • 11.12.2 Diagnostica Stago/Trinity Biotech Business Overview
    • 11.12.3 Diagnostica Stago/Trinity Biotech STD Diagnostics Introduction
    • 11.12.4 Diagnostica Stago/Trinity Biotech Revenue in STD Diagnostics Business (2017-2022)
    • 11.12.5 Diagnostica Stago/Trinity Biotech Recent Developments
  • 11.13 Diamedix
    • 11.13.1 Diamedix Company Details
    • 11.13.2 Diamedix Business Overview
    • 11.13.3 Diamedix STD Diagnostics Introduction
    • 11.13.4 Diamedix Revenue in STD Diagnostics Business (2017-2022)
    • 11.13.5 Diamedix Recent Developments
  • 11.14 Polymedco
    • 11.14.1 Polymedco Company Details
    • 11.14.2 Polymedco Business Overview
    • 11.14.3 Polymedco STD Diagnostics Introduction
    • 11.14.4 Polymedco Revenue in STD Diagnostics Business (2017-2022)
    • 11.14.5 Polymedco Recent Developments
  • 11.15 Qiagen
    • 11.15.1 Qiagen Company Details
    • 11.15.2 Qiagen Business Overview
    • 11.15.3 Qiagen STD Diagnostics Introduction
    • 11.15.4 Qiagen Revenue in STD Diagnostics Business (2017-2022)
    • 11.15.5 Qiagen Recent Developments
  • 11.16 Roche
    • 11.16.1 Roche Company Details
    • 11.16.2 Roche Business Overview
    • 11.16.3 Roche STD Diagnostics Introduction
    • 11.16.4 Roche Revenue in STD Diagnostics Business (2017-2022)
    • 11.16.5 Roche Recent Developments
  • 11.17 SDIX
    • 11.17.1 SDIX Company Details
    • 11.17.2 SDIX Business Overview
    • 11.17.3 SDIX STD Diagnostics Introduction
    • 11.17.4 SDIX Revenue in STD Diagnostics Business (2017-2022)
    • 11.17.5 SDIX Recent Developments
  • 11.18 Sequenom
    • 11.18.1 Sequenom Company Details
    • 11.18.2 Sequenom Business Overview
    • 11.18.3 Sequenom STD Diagnostics Introduction
    • 11.18.4 Sequenom Revenue in STD Diagnostics Business (2017-2022)
    • 11.18.5 Sequenom Recent Developments
  • 11.19 Siemens
    • 11.19.1 Siemens Company Details
    • 11.19.2 Siemens Business Overview
    • 11.19.3 Siemens STD Diagnostics Introduction
    • 11.19.4 Siemens Revenue in STD Diagnostics Business (2017-2022)
    • 11.19.5 Siemens Recent Developments
  • 11.20 Sienco
    • 11.20.1 Sienco Company Details
    • 11.20.2 Sienco Business Overview
    • 11.20.3 Sienco STD Diagnostics Introduction
    • 11.20.4 Sienco Revenue in STD Diagnostics Business (2017-2022)
    • 11.20.5 Sienco Recent Developments
  • 11.21 Sysmex
    • 11.21.1 Sysmex Company Details
    • 11.21.2 Sysmex Business Overview
    • 11.21.3 Sysmex STD Diagnostics Introduction
    • 11.21.4 Sysmex Revenue in STD Diagnostics Business (2017-2022)
    • 11.21.5 Sysmex Recent Developments
  • 11.22 Takara Bio
    • 11.22.1 Takara Bio Company Details
    • 11.22.2 Takara Bio Business Overview
    • 11.22.3 Takara Bio STD Diagnostics Introduction
    • 11.22.4 Takara Bio Revenue in STD Diagnostics Business (2017-2022)
    • 11.22.5 Takara Bio Recent Developments
  • 11.23 ThermoFisher
    • 11.23.1 ThermoFisher Company Details
    • 11.23.2 ThermoFisher Business Overview
    • 11.23.3 ThermoFisher STD Diagnostics Introduction
    • 11.23.4 ThermoFisher Revenue in STD Diagnostics Business (2017-2022)
    • 11.23.5 ThermoFisher Recent Developments
  • 11.24 Tosoh
    • 11.24.1 Tosoh Company Details
    • 11.24.2 Tosoh Business Overview
    • 11.24.3 Tosoh STD Diagnostics Introduction
    • 11.24.4 Tosoh Revenue in STD Diagnostics Business (2017-2022)
    • 11.24.5 Tosoh Recent Developments
  • 11.25 Wako
    • 11.25.1 Wako Company Details
    • 11.25.2 Wako Business Overview
    • 11.25.3 Wako STD Diagnostics Introduction
    • 11.25.4 Wako Revenue in STD Diagnostics Business (2017-2022)
    • 11.25.5 Wako Recent Developments
  • 11.26 Zycare/Alere
    • 11.26.1 Zycare/Alere Company Details
    • 11.26.2 Zycare/Alere Business Overview
    • 11.26.3 Zycare/Alere STD Diagnostics Introduction
    • 11.26.4 Zycare/Alere Revenue in STD Diagnostics Business (2017-2022)
    • 11.26.5 Zycare/Alere Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer

LIST OF TABLES

List of Tables

  • Table 1. Global STD Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Chlamydia Testing
  • Table 3. Key Players of Syphilis Testing
  • Table 4. Key Players of Gonorrhea Testing
  • Table 5. Key Players of Herpes Simplex Virus Testing
  • Table 6. Key Players of Human Papilloma Virus Testing
  • Table 7. Key Players of Human Immunodeficiency Virus Testing
  • Table 8. Key Players of Chancroid Testing
  • Table 9. Global STD Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 10. Global STD Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 11. Global STD Diagnostics Market Size by Region (2017-2022) & (US$ Million)
  • Table 12. Global STD Diagnostics Market Share by Region (2017-2022)
  • Table 13. Global STD Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 14. Global STD Diagnostics Market Share by Region (2023-2028)
  • Table 15. STD Diagnostics Market Trends
  • Table 16. STD Diagnostics Market Drivers
  • Table 17. STD Diagnostics Market Challenges
  • Table 18. STD Diagnostics Market Restraints
  • Table 19. Global STD Diagnostics Revenue by Players (2017-2022) & (US$ Million)
  • Table 20. Global STD Diagnostics Revenue Share by Players (2017-2022)
  • Table 21. Global Top STD Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in STD Diagnostics as of 2021)
  • Table 22. Ranking of Global Top STD Diagnostics Companies by Revenue (US$ Million) in 2021
  • Table 23. Global 5 Largest Players Market Share by STD Diagnostics Revenue (CR5 and HHI) & (2017-2022)
  • Table 24. Key Players Headquarters and Area Served
  • Table 25. Key Players STD Diagnostics Product Solution and Service
  • Table 26. Date of Enter into STD Diagnostics Market
  • Table 27. Mergers & Acquisitions, Expansion Plans
  • Table 28. Global STD Diagnostics Market Size by Type (2017-2022) & (US$ Million)
  • Table 29. Global STD Diagnostics Revenue Market Share by Type (2017-2022)
  • Table 30. Global STD Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 31. Global STD Diagnostics Revenue Market Share by Type (2023-2028)
  • Table 32. Global STD Diagnostics Market Size by Application (2017-2022) & (US$ Million)
  • Table 33. Global STD Diagnostics Revenue Share by Application (2017-2022)
  • Table 34. Global STD Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. Global STD Diagnostics Revenue Share by Application (2023-2028)
  • Table 36. North America STD Diagnostics Market Size by Type (2017-2022) & (US$ Million)
  • Table 37. North America STD Diagnostics Market Size by Type (2023-2028) & (US$ Million)
  • Table 38. North America STD Diagnostics Market Size by Application (2017-2022) & (US$ Million)
  • Table 39. North America STD Diagnostics Market Size by Application (2023-2028) & (US$ Million)
  • Table 40. North America STD Diagnostics Market Size by Country (2017-2022) & (US$ Million)
  • Table 41. North America STD Diagnostics Market Size by Country (2023-2028) & (US$ Million)
  • Table 42. Europe STD Diagnostics Market Size by Type (2017-2022) & (US$ Million)
  • Table 43. Europe STD Diagnostics Market Size by Type (2023-2028) & (US$ Million)
  • Table 44. Europe STD Diagnostics Market Size by Application (2017-2022) & (US$ Million)
  • Table 45. Europe STD Diagnostics Market Size by Application (2023-2028) & (US$ Million)
  • Table 46. Europe STD Diagnostics Market Size by Country (2017-2022) & (US$ Million)
  • Table 47. Europe STD Diagnostics Market Size by Country (2023-2028) & (US$ Million)
  • Table 48. Asia Pacific STD Diagnostics Market Size by Type (2017-2022) & (US$ Million)
  • Table 49. Asia Pacific STD Diagnostics Market Size by Type (2023-2028) & (US$ Million)
  • Table 50. Asia Pacific STD Diagnostics Market Size by Application (2017-2022) & (US$ Million)
  • Table 51. Asia Pacific STD Diagnostics Market Size by Application (2023-2028) & (US$ Million)
  • Table 52. Asia Pacific STD Diagnostics Market Size by Region (2017-2022) & (US$ Million)
  • Table 53. Asia Pacific STD Diagnostics Market Size by Region (2023-2028) & (US$ Million)
  • Table 54. Latin America STD Diagnostics Market Size by Type (2017-2022) & (US$ Million)
  • Table 55. Latin America STD Diagnostics Market Size by Type (2023-2028) & (US$ Million)
  • Table 56. Latin America STD Diagnostics Market Size by Application (2017-2022) & (US$ Million)
  • Table 57. Latin America STD Diagnostics Market Size by Application (2023-2028) & (US$ Million)
  • Table 58. Latin America STD Diagnostics Market Size by Country (2017-2022) & (US$ Million)
  • Table 59. Latin America STD Diagnostics Market Size by Country (2023-2028) & (US$ Million)
  • Table 60. Middle East and Africa STD Diagnostics Market Size by Type (2017-2022) & (US$ Million)
  • Table 61. Middle East and Africa STD Diagnostics Market Size by Type (2023-2028) & (US$ Million)
  • Table 62. Middle East and Africa STD Diagnostics Market Size by Application (2017-2022) & (US$ Million)
  • Table 63. Middle East and Africa STD Diagnostics Market Size by Application (2023-2028) & (US$ Million)
  • Table 64. Middle East and Africa STD Diagnostics Market Size by Country (2017-2022) & (US$ Million)
  • Table 65. Middle East and Africa STD Diagnostics Market Size by Country (2023-2028) & (US$ Million)
  • Table 66. Abbott Company Details
  • Table 67. Abbott Business Overview
  • Table 68. Abbott STD Diagnostics Product
  • Table 69. Abbott Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 70. Abbott Recent Developments
  • Table 71. ADI/American Diagnostica Company Details
  • Table 72. ADI/American Diagnostica Business Overview
  • Table 73. ADI/American Diagnostica STD Diagnostics Product
  • Table 74. ADI/American Diagnostica Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 75. ADI/American Diagnostica Recent Developments
  • Table 76. Agilent Technologies Company Details
  • Table 77. Agilent Technologies Business Overview
  • Table 78. Agilent Technologies STD Diagnostics Product
  • Table 79. Agilent Technologies Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 80. Agilent Technologies Recent Developments
  • Table 81. Alere/Biosite/Inverness Company Details
  • Table 82. Alere/Biosite/Inverness Business Overview
  • Table 83. Alere/Biosite/Inverness STD Diagnostics Product
  • Table 84. Alere/Biosite/Inverness Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 85. Alere/Biosite/Inverness Recent Developments
  • Table 86. Axis-Shield Company Details
  • Table 87. Axis-Shield Business Overview
  • Table 88. Axis-Shield STD Diagnostics Product
  • Table 89. Axis-Shield Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 90. Axis-Shield Recent Developments
  • Table 91. Beckman Coulter/Danaher Company Details
  • Table 92. Beckman Coulter/Danaher Business Overview
  • Table 93. Beckman Coulter/Danaher STD Diagnostics Product
  • Table 94. Beckman Coulter/Danaher Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 95. Beckman Coulter/Danaher Recent Developments
  • Table 96. Becton Dickinson Company Details
  • Table 97. Becton Dickinson Business Overview
  • Table 98. Becton Dickinson STD Diagnostics Product
  • Table 99. Becton Dickinson Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 100. Becton Dickinson Recent Developments
  • Table 101. Bio/Data Company Details
  • Table 102. Bio/Data Business Overview
  • Table 103. Bio/Data STD Diagnostics Product
  • Table 104. Bio/Data Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 105. Bio/Data Recent Developments
  • Table 106. Decode Genetics Company Details
  • Table 107. Decode Genetics Business Overview
  • Table 108. Decode Genetics STD Diagnostics Product
  • Table 109. Decode Genetics Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 110. Decode Genetics Recent Developments
  • Table 111. Diadexus Company Details
  • Table 112. Diadexus Business Overview
  • Table 113. Diadexus STD Diagnostics Product
  • Table 114. Diadexus Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 115. Diadexus Recent Developments
  • Table 116. Diagnocure Company Details
  • Table 117. Diagnocure Business Overview
  • Table 118. Diagnocure STD Diagnostics Product
  • Table 119. Diagnocure Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 120. Diagnocure Recent Developments
  • Table 121. Diagnostica Stago/Trinity Biotech Company Details
  • Table 122. Diagnostica Stago/Trinity Biotech Business Overview
  • Table 123. Diagnostica Stago/Trinity Biotech STD Diagnostics Product
  • Table 124. Diagnostica Stago/Trinity Biotech Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 125. Diagnostica Stago/Trinity Biotech Recent Developments
  • Table 126. Diamedix Company Details
  • Table 127. Diamedix Business Overview
  • Table 128. Diamedix STD Diagnostics Product
  • Table 129. Diamedix Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 130. Diamedix Recent Developments
  • Table 131. Polymedco Company Details
  • Table 132. Polymedco Business Overview
  • Table 133. Polymedco STD Diagnostics Product
  • Table 134. Polymedco Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 135. Polymedco Recent Developments
  • Table 136. Qiagen Company Details
  • Table 137. Qiagen Business Overview
  • Table 138. Qiagen STD Diagnostics Product
  • Table 139. Qiagen Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 140. Qiagen Recent Developments
  • Table 141. Roche Company Details
  • Table 142. Roche Business Overview
  • Table 143. Roche STD Diagnostics Product
  • Table 144. Roche Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 145. Roche Recent Developments
  • Table 146. SDIX Company Details
  • Table 147. SDIX Business Overview
  • Table 148. SDIX STD Diagnostics Product
  • Table 149. SDIX Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 150. SDIX Recent Developments
  • Table 151. Sequenom Company Details
  • Table 152. Sequenom Business Overview
  • Table 153. Sequenom STD Diagnostics Product
  • Table 154. Sequenom Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 155. Sequenom Recent Developments
  • Table 156. Siemens Company Details
  • Table 157. Siemens Business Overview
  • Table 158. Siemens STD Diagnostics Product
  • Table 159. Siemens Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 160. Siemens Recent Developments
  • Table 161. Sienco Company Details
  • Table 162. Sienco Business Overview
  • Table 163. Sienco STD Diagnostics Product
  • Table 164. Sienco Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 165. Sienco Recent Developments
  • Table 166. Sysmex Company Details
  • Table 167. Sysmex Business Overview
  • Table 168. Sysmex STD Diagnostics Product
  • Table 169. Sysmex Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 170. Sysmex Recent Developments
  • Table 171. Takara Bio Company Details
  • Table 172. Takara Bio Business Overview
  • Table 173. Takara Bio STD Diagnostics Product
  • Table 174. Takara Bio Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 175. Takara Bio Recent Developments
  • Table 176. ThermoFisher Company Details
  • Table 177. ThermoFisher Business Overview
  • Table 178. ThermoFisher STD Diagnostics Product
  • Table 179. ThermoFisher Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 180. ThermoFisher Recent Developments
  • Table 181. Tosoh Company Details
  • Table 182. Tosoh Business Overview
  • Table 183. Tosoh STD Diagnostics Product
  • Table 184. Tosoh Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 185. Tosoh Recent Developments
  • Table 186. Wako Company Details
  • Table 187. Wako Business Overview
  • Table 188. Wako STD Diagnostics Product
  • Table 189. Wako Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 190. Wako Recent Developments
  • Table 191. Zycare/Alere Company Details
  • Table 192. Zycare/Alere Business Overview
  • Table 193. Zycare/Alere STD Diagnostics Product
  • Table 194. Zycare/Alere Revenue in STD Diagnostics Business (2017-2022) & (US$ Million)
  • Table 195. Zycare/Alere Recent Developments
  • Table 196. Research Programs/Design for This Report
  • Table 197. Key Data Information from Secondary Sources
  • Table 198. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global STD Diagnostics Market Share by Type: 2021 VS 2028
  • Figure 2. Chlamydia Testing Features
  • Figure 3. Syphilis Testing Features
  • Figure 4. Gonorrhea Testing Features
  • Figure 5. Herpes Simplex Virus Testing Features
  • Figure 6. Human Papilloma Virus Testing Features
  • Figure 7. Human Immunodeficiency Virus Testing Features
  • Figure 8. Chancroid Testing Features
  • Figure 9. Global STD Diagnostics Market Share by Application: 2021 VS 2028
  • Figure 10. Laboratory Testing Case Studies
  • Figure 11. Point of Care Testing Case Studies
  • Figure 12. STD Diagnostics Report Years Considered
  • Figure 13. Global STD Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 14. Global STD Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 15. Global STD Diagnostics Market Share by Region: 2021 VS 2028
  • Figure 16. Global STD Diagnostics Market Share by Players in 2021
  • Figure 17. Global Top STD Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in STD Diagnostics as of 2021)
  • Figure 18. The Top 10 and 5 Players Market Share by STD Diagnostics Revenue in 2021
  • Figure 19. North America STD Diagnostics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 20. North America STD Diagnostics Market Size Market Share by Type (2017-2028)
  • Figure 21. North America STD Diagnostics Market Size Market Share by Application (2017-2028)
  • Figure 22. North America STD Diagnostics Market Size Share by Country (2017-2028)
  • Figure 23. United States STD Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 24. Canada STD Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 25. Europe STD Diagnostics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 26. Europe STD Diagnostics Market Size Market Share by Type (2017-2028)
  • Figure 27. Europe STD Diagnostics Market Size Market Share by Application (2017-2028)
  • Figure 28. Europe STD Diagnostics Market Size Share by Country (2017-2028)
  • Figure 29. Germany STD Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. France STD Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. U.K. STD Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Italy STD Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Russia STD Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 34. Nordic Countries STD Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 35. Asia-Pacific STD Diagnostics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 36. Asia Pacific STD Diagnostics Market Size Market Share by Type (2017-2028)
  • Figure 37. Asia Pacific STD Diagnostics Market Size Market Share by Application (2017-2028)
  • Figure 38. Asia Pacific STD Diagnostics Market Size Share by Region (2017-2028)
  • Figure 39. China STD Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Japan STD Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. South Korea STD Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. Southeast Asia STD Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. India STD Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 44. Australia STD Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 45. Latin America STD Diagnostics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 46. Latin America STD Diagnostics Market Size Market Share by Type (2017-2028)
  • Figure 47. Latin America STD Diagnostics Market Size Market Share by Application (2017-2028)
  • Figure 48. Latin America STD Diagnostics Market Size Share by Country (2017-2028)
  • Figure 49. Mexico STD Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 50. Brazil STD Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 51. Middle East & Africa STD Diagnostics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 52. Middle East and Africa STD Diagnostics Market Size Market Share by Type (2017-2028)
  • Figure 53. Middle East and Africa STD Diagnostics Market Size Market Share by Application (2017-2028)
  • Figure 54. Middle East and Africa STD Diagnostics Market Size Share by Country (2017-2028)
  • Figure 55. Turkey STD Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. Saudi Arabia STD Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 57. UAE STD Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 58. Abbott Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 59. ADI/American Diagnostica Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 60. Agilent Technologies Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 61. Alere/Biosite/Inverness Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 62. Axis-Shield Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 63. Beckman Coulter/Danaher Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 64. Becton Dickinson Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 65. Bio/Data Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 66. Decode Genetics Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 67. Diadexus Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 68. Diagnocure Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 69. Diagnostica Stago/Trinity Biotech Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 70. Diamedix Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 71. Polymedco Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 72. Qiagen Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 73. Roche Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 74. SDIX Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 75. Sequenom Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 76. Siemens Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 77. Sienco Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 78. Sysmex Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 79. Takara Bio Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 80. ThermoFisher Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 81. Tosoh Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 82. Wako Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 83. Zycare/Alere Revenue Growth Rate in STD Diagnostics Business (2017-2022)
  • Figure 84. Bottom-up and Top-down Approaches for This Report
  • Figure 85. Data Triangulation
  • Figure 86. Key Executives Interviewed
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!